Series B final close · Healthtech

4baseCare adds ₹38 crore to complete its Series B

The top-up led by growX ventures and Infosys takes the round’s cumulative funding to ₹128 crore.

4baseCare disclosed an additional ₹38 crore on June 11 to complete its Series B at ₹128 crore. growX ventures and Infosys led the top-up, with participation from existing investors; the previously raised ₹90 crore is separate from the new infusion.

The company plans to expand its genomics laboratory network and scale OncoTwin, its AI-based precision oncology platform. Its work combines cancer testing with clinical and genomic data intended to make treatment insights more relevant to underrepresented populations.

Use of funds

Expand genomics laboratory network internationally

Scale OncoTwin precision oncology platform

Funding history

Series B final close · This round₹380M
Series B first close₹900M

Sources

  1. Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globaleconomictimes.indiatimes.com · Jun 11, 2026
  2. C-CAMP on 4baseCare SeriesB finalcloselinkedin.com